INSTANT STREAMING COURSE
Share:

How to go Paperless in an FDA-Regulated Environment using Electronic Workflow Signature Approvals and Electronic Records

This course equips regulated-industry professionals with the decision framework and implementation knowledge needed to adopt electronic records and signature workflows in full alignment with 21 CFR Part 11, reducing compliance risk while improving operational efficiency. This course is designed for professionals in FDA-regulated industries involved in systems compliance, records management, or validation oversight.

REGISTER FOR THE COURSE

US $190 per learner

30-Days Unlimited Streaming Access

/* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } /* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } .accordion-header::after { content: "◯"; font-size: 18px; transition: transform 0.25s ease; } .accordion-item.active .accordion-header::after { transform: rotate(90deg); }

REGISTER FOR THE COURSE

To Get 30-Day Access to ONLY this Course 

US $190 per learner
  • This course is Included in Subscription Pack
Subscription include access to entire Learning Library
/* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } /* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } .accordion-header::after { content: "◯"; font-size: 18px; transition: transform 0.25s ease; } .accordion-item.active .accordion-header::after { transform: rotate(90deg); }
  • Faculty
    Carolyn Troiano
  • Duration
    75 Minutes
  • Course ID
    TF2146
  • Ask the Expert
    Included
  • Presentation Handout
    & Templates
  • Assessment
    & Certification Included

About the Course

Operating in a paperless environment under FDA oversight requires more than adopting software — it demands a structured approach to security, access controls, signature authentication, and audit readiness. 21 CFR Part 11 defines specific requirements for electronic records and electronic signatures, and gaps in implementation carry direct regulatory consequences. Organizations that proceed without a validated, compliant framework risk audit findings, system failures, and costly remediation.

This course addresses the full scope of ER/ES implementation: from evaluating readiness and conducting cost-benefit analysis, to managing organizational change, defining roles, and integrating electronic signature capability into existing applications. It also prepares professionals for FDA audits targeting these systems, covering what inspectors look for and how compliant workflows should be documented and defended.

  • Build a Compliant ER/ES Implementation Strategy:

    Professionals will leave with a structured approach to evaluating, implementing, and maintaining electronic records and signature systems that satisfy FDA's 21 CFR Part 11 requirements. This includes understanding the System Development Life Cycle for validation, identifying key roles, and documenting rationalization — all essential before moving to a paperless workflow.

  • Assess Risk and Prepare for Regulatory Scrutiny:

    FDA audits increasingly scrutinize electronic record and signature systems. This course addresses known implementation risks, mitigation strategies, and what constitutes audit-ready documentation. Understanding both the threats and the operational opportunities of ER/ES capability positions professionals to make informed decisions that hold up under regulatory review.

Key Areas Covered

  • 21 CFR Part 11 requirements for electronic records and electronic signatures, including security controls and signature authentication
  • Pros, cons, and cost-benefit analysis of implementing ER/ES capability in a regulated environment
  • System Development Life Cycle (SDLC) approach to validation of ER/ES systems
  • Risk assessment for ER/ES implementation and methods for mitigating identified threats
  • Organizational change management and key roles required to implement and sustain ER/ES capability
  • Integration of ER/ES into existing applications and documentation of rationalization
  • Preparing applications and documentation for FDA audit scrutiny involving electronic records and signatures
  • Real-world examples of ER/ES implementation outcomes, including both successful and unsuccessful cases

Who Must Attend

  • QA/QC Departments
  • Information Technology Departments
  • Validation Departments
  • Clinical Data Managers and Scientists
  • Analytical Chemists
  • Laboratory Managers
  • CSV Specialists
  • GMP Training Specialists

Quality training, expert insights, and answers that matter. Know your Expert

Carolyn Troiano

Carolyn Troiano brings more than 30 years of direct experience in computer system validation across pharmaceutical, medical device, animal health, tobacco, and other FDA-regulated industries. She was involved in the development of 21 CFR Part 11 through collaboration with FDA and industry representatives, and has built validation programs and ER/ES strategies for major pharmaceutical companies in the US and Europe. She currently consults on computer system validation and large-scale IT implementation.

If you would like to request a Proforma invoice to sign up for this course. please click here

Commonly Asked Questions About This Subject

The following questions address practical regulatory, compliance, validation, quality, operational, and inspection-related considerations commonly associated with this subject.

What causes electronic records and electronic signature systems to fail FDA inspection despite having validation documentation?

FDA inspection concerns often arise when validation documentation exists but the company cannot demonstrate that the system remains controlled during routine operation. Inspectors frequently move beyond the original validation package and examine how the system is managed after implementation.


A recurring issue is that teams complete validation activities but do not maintain the same level of discipline when changes occur. User roles may expand, workflows may be modified, configurations may change, or system issues may be handled without a clear assessment of impact.


During inspections, questions often focus on ownership and decision-making. Reviewers want to understand who evaluated risks, who approved changes, and how the company determined that the validated state was maintained.


A system becomes difficult to defend when records show that implementation was completed but provide limited evidence of ongoing control. The strongest evidence connects validation decisions, operational use, change management, and oversight activities into a clear history of control.

How should companies determine whether an electronic workflow is compliant when replacing paper approvals?

Replacing paper approvals with electronic workflows requires careful evaluation of whether the process still maintains appropriate control over review, approval, accountability, and record integrity. The software capability alone does not determine whether the workflow is defensible.


A frequent problem occurs when teams configure workflows based on existing business practices without examining whether the approval sequence still reflects the intended quality decision process. Inspectors may question whether a signature represents meaningful review or simply a digital version of a manual step.


Workflow decisions become difficult to defend when responsibilities, approval meaning, and escalation paths are unclear. Problems often appear when business users assume the system configuration automatically provides the required controls.


A well-controlled workflow has documented decisions behind its design. The evidence that carries weight shows why approvals occur at specific points, who is responsible for each decision, and how the electronic process supports the intended control strategy.

Which documentation weaknesses create the greatest FDA inspection concerns for electronic records and signatures?

Documentation weaknesses involving access decisions, system changes, and record management frequently create inspection concerns because they affect whether the company can demonstrate control over electronic information. A functioning system does not eliminate the need to explain how control decisions were made.


One recurring issue involves user access management. Inspectors often ask why individuals received specific permissions, who approved those permissions, and whether access remained appropriate after responsibilities changed.


Change documentation is another area where problems develop. A system update may appear routine, but missing impact assessments or unclear approval rationale can raise questions about whether the validated state was preserved.


The strongest documentation demonstrates accountability rather than simply recording activity. Reviewers need to see who made decisions, what information supported those decisions, and how risks were evaluated. Electronic records systems become harder to defend when documentation shows completed tasks but not the reasoning behind them.

How can companies avoid compliance problems when business priorities push for faster paperless implementation?

Compliance problems often develop when implementation timelines move ahead of decisions about ownership, workflow controls, and system responsibilities. Teams may successfully deploy technology but later discover that important control decisions were never clearly defined.


A practical issue seen during reviews is that business users, IT teams, validation groups, and quality functions may each assume another group owns specific decisions. This creates gaps when questions arise about workflow logic, access controls, system changes, or record reliability.


Implementation choices become difficult to defend when compliance considerations are added after configuration decisions have already been made. Late changes often create additional validation work, documentation gaps, and operational disruption.


A controlled implementation establishes accountability before system use begins. The strongest evidence shows that responsible groups evaluated risks, agreed on control expectations, and maintained oversight throughout the system lifecycle rather than treating compliance as a final review step.

Ready to Strengthen Your Team? Let’s Build Your Training Plan.

Whether you’re looking for a single onsite workshop or a multi-team training series, we’ll help you design a program that fits your goals, timelines, and operational reality.

Your team deserves the clarity.
Your organization deserves the confidence.

Upcoming Courses

Your TalkFDA Webinar Experience

When you reserve your seat, everything is organized for you — from access to certification from one place.

1. Confirmation

You receive a confirmation email and your course appears instantly in your TalkFDA dashboard.

2. Your Course Hub
Your TalkFDA course page becomes your central hub where you can watch the course, access materials, and manage your learning.

3. Access course materials
The presentation handout and other materials can be downloaded inside the Course Player. You could use Discussion feature there to ask your questions.

4. Watch The Streaming and Complete your Course
The course playback will be available on the same course page. You could pause and continue or you can revisit important sections.
5. Earn Your Certificate
Complete the course and your certificate is unlocked automatically in your learning history.

The challenge with training is rarely signing up. It’s what happens afterward, when access, materials, & certification aren’t accessible from one place.
With TalkFDA Courses, Everything you need Live in One Place.
Simple. Organized. Professional.
Go ahead and Take the Course with confidence.

Our students love us ❤️

"TalkFDA’s courses are well-structured and easy to follow. The content is practical, up-to-date, and delivered by industry experts. The certificate also helped me in my professional development!"

Dr. Lisa Carter – Regulatory Affairs Manager
"I found the training extremely valuable for understanding FDA regulations. The explanations were clear, and the flexibility to learn at my own pace made it even better. Highly recommend!"

Mark Reynolds – Quality Assurance Specialist
"The courses on TalkFDA are a must-have for anyone working in regulatory affairs. The content is detailed yet easy to grasp, and the platform is very user-friendly. Great experience!"

Priya Sharma – Compliance Consultant

People who took this Course, also viewed